Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients

Abstract Background Circulating interleukin-6 (IL-6) improves outcome prediction for second primary cancer (SPC) in head and neck cancer (HNC) patients. This study aimed to identify factors associated with IL-6 serum levels in HNC patients. Methods This study was conducted as part of a phase III che...

Full description

Bibliographic Details
Main Authors: Sylvine Carrondo Cottin, Stéphane Turcotte, Pierre Douville, François Meyer, Isabelle Bairati
Format: Article
Language:English
Published: BioMed Central 2018-05-01
Series:Cancers of the Head & Neck
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41199-018-0029-5